G27919IH

Summary
GlyTouCan ID
G27919IH
IUPAC Condensed
GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc(b1-
Motifs
N-Glycan complex N-acetyllactosamine Type 2 LN
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1624.6
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
GlycoGene Database (GGDB)
Displaying all 2 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
MGAT4A UDP-GlcNAc
G27919IH
Asn-X
G03445UI
Asn-X
MGAT3 UDP-GlcNAc
G27919IH
Asn-X
G85767HW
Asn-X
KEGG BRITE Database
KEGG ID
References
GALAXY
Glucose Units
ODS
13.1
Amide
6.3
Degrading Enzymes
Displaying entries 1 - 5 of 8 in total
Enzyme Substrate Product
α-Fucosidase
G27919IH
G89993FE
α-Galactosidase
G56340GX
G27919IH
α-Glucuronidase
G34875XC
G27919IH
α-Sialidase
G63787RZ
G27919IH
α-Sialidase
G23295TF
G27919IH
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:a-dman-HEX-1:5
10b:b-dglc-HEX-1:5
11s:n-acetyl
12b:b-dgal-HEX-1:5
13b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:5o(6+1)9d
9:9o(2+1)10d
10:10d(2+1)11n
11:10o(4+1)12d
12:1o(6+1)13d
WURCS
WURCS=2.0/5,9,8/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][a1221m-1a_1-5]/1-1-2-3-1-3-1-4-5/a4-b1_a6-i1_b4-c1_c3-d1_c6-f1_d2-e1_f2-g1_g4-h1
Literature
Displaying entries 1 - 10 of 33 in total
PubMed ID Title First Author Publication Date Source
33242084 Post-natal developmental changes in the composition of the rat neocortical N-glycome Klarić Thomas S 2021-06-03
  • GlyGen
33383989 Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis Wongtrakul-Kish K 2021 Feb 5
  • GlyGen
30674035 Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis Costa J 2019 Jan 23
  • GlyGen
24680513 Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species Adamczyk B 2014 May 07
  • GlyGen
  • PubChem
24090084 Site-Specific Glycan-Peptide Analysis for Determination of N-Glycoproteome Heterogeneity Parker BL 2013 Dec 6
  • GlyGen
  • PubChem
20578731 Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia Stanta Johannes L 2010-09-03
  • GlyGen
14693911 Site-specific N-glycosylation of chicken serum IgG Suzuki Noriko 2004-03
  • GlyGen
12652077 Structural studies on IgG oligosaccharides of patients with primary Sjogren's syndrome Kuroda Y 2002 Jan
  • GlyGen
  • PubChem
11498595 Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design Saphire EO 2001 Aug 10
  • PubChem
10207177 Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells Rudd PM 1999 May
  • GlyGen
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.3.0

Last updated: August 4, 2025